Company: BDRX
Filing Date: 2025-11-17
Form Type: F-1
Source: 0001214659-25-016821
Chunk: 50

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-17
Form: F-1
Chunk 50
---
 or warrants for the purposes of computing the percentage of
beneficial ownership of that person and any group of which that person is a member, but are not deemed outstanding for the purpose of
computing the percentage of beneficial ownership for any other person. Unless otherwise indicated, the address for each holder listed
below is Biodexa Pharmaceuticals plc, 1 Caspian Point, Caspian Way, Cardiff, CF10 4DQ, United Kingdom. All holders of Ordinary Shares,
including those shareholders listed below, have the same voting rights with respect to such shares.

| Name of Beneficial Owner                                   |     | Amount and   
 Nature       
 Of Ownership |             |     | Percent  
 of Class |   |
| Directors and Senior Management:                           |     |              |             |     |          |   |
| Ann Merchant (1)                                           |     |              |  12,600,000 |     |          | * |
| Stephen Parker (2)                                         |     |              |  25,200,000 |     |          | * |
| Stephen Stamp (3)                                          |     |              |  37,632,375 |     |          | * |
| Simon Turton (4)                                           |     |              |  12,602,765 |     |          | * |
| Sijmen de Vries (5)                                        |     |              |  12,600,000 |     |          | * |
| Directors and senior management as a group (5 persons) (6) |     |              | 100,635,140 |     |          | * |

________________

| * | Represents beneficial ownership of less than one percent. |

| 32 |

| (1) | Shares owned by Ms. Merchant are Ordinary Shares subject to outstanding stock options which are exercisable 
 at November 1, 2025 or will become exercisable within 60 days after such date.                              |

| (2) | Shares owned by Dr. Parker are Ordinary Shares subject to outstanding stock options which are exercisable 
 at November 1, 2025 or will become exercisable within 60 days after such date.                            |

| (3) | Shares owned by Mr. Stamp are Ordinary Shares subject to outstanding stock options which are exercisable 
 at November 1, 2025 or will become exercisable within 60 days after such date.                           |

| (4) | Shares owned by Dr. Turton include 12,600,